Does hydrocortisone (cortisol) increase total leukocytes (white blood cell count)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hydrocortisone Increases Total Leukocyte Count

Yes, hydrocortisone does increase total leukocyte (white blood cell) count. This effect is well-documented and can be clinically significant when interpreting laboratory results in patients receiving corticosteroid therapy.

Mechanism and Magnitude of Effect

  • Hydrocortisone causes leukocytosis primarily by increasing the number of circulating neutrophils (polymorphonuclear cells) in the bloodstream 1, 2
  • The increase in white blood cell count peaks approximately 48 hours after hydrocortisone administration 1
  • The magnitude of increase is dose-dependent:
    • High-dose hydrocortisone can increase WBC count by up to 4.84 × 10^9/L 1
    • Medium-dose hydrocortisone typically increases WBC count by approximately 1.7 × 10^9/L 1
    • Low-dose hydrocortisone causes minimal increases of around 0.3 × 10^9/L 1

Cellular Mechanisms

  • Hydrocortisone reduces the expression of neutrophil adhesion molecules, particularly:
    • Mac-1 (CD11b) - decreased by approximately 40-50% 3
    • L-selectin (CD62L) - decreased by approximately 17-30% 3
  • This reduced adhesion molecule expression decreases neutrophil margination (adherence to vessel walls) and increases the number of circulating neutrophils 4, 3
  • Hydrocortisone also increases the velocity of rolling leukocytes along vessel walls, reducing their ability to extravasate into tissues 4

Differential Effects on White Blood Cell Types

  • The leukocytosis from hydrocortisone is predominantly due to increased neutrophils 2
  • Other white blood cell changes typically include:
    • Monocytosis (increased monocytes) 2
    • Eosinopenia (decreased eosinophils) 2
    • Variable lymphopenia (decreased lymphocytes) 2

Clinical Implications

  • Hydrocortisone-induced leukocytosis can persist for the duration of therapy, though it may decrease somewhat over time even with continued treatment 2
  • When interpreting WBC counts in patients on hydrocortisone, clinicians should consider that:
    • Increases up to 4.84 × 10^9/L within 48 hours after high-dose steroids may be due to the medication alone 1
    • Larger increases, especially after low-dose steroids, suggest other causes of leukocytosis such as infection 1
  • The FDA drug label for hydrocortisone (IV) specifically lists leukocytosis as a known adverse reaction 5

Important Considerations for Clinical Practice

  • Hydrocortisone-induced leukocytosis can complicate the diagnosis of infection, particularly in immunocompromised patients 2
  • Key differentiating features between steroid-induced leukocytosis and infection:
    • Steroid-induced leukocytosis rarely shows a significant "left shift" (>6% band forms) 2
    • Toxic granulation in neutrophils is uncommon in steroid-induced leukocytosis but often present in infection 2
  • In septic shock management, hydrocortisone at doses of 200 mg/day may be used when fluid resuscitation and vasopressors fail to restore hemodynamic stability 6

Understanding this predictable effect of hydrocortisone on white blood cell count is essential for accurate laboratory interpretation and avoiding unnecessary diagnostic procedures or treatments when evaluating patients on corticosteroid therapy.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.